<DOC>
	<DOCNO>NCT00643994</DOCNO>
	<brief_summary>The purpose study determine effect CyberKnife radiosurgery patient early stage organ-confined prostate cancer .</brief_summary>
	<brief_title>CyberKnife Radiosurgery Organ-Confined Prostate Cancer : Homogenous Dose Distribution</brief_title>
	<detailed_description>The CyberKnife Robotic Radiosurgery System unique radiosurgical system capable treating tumor anywhere body noninvasively sub-millimeter accuracy . The CyberKnife System deliver radiation use precise target methodology allow focal treatment margin around target , thus limit volume adjacent tissue receive high dos radiation . This turn allow delivery high dos radiation prostate short series treatment .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patient must least 18 year age Histologically proven prostate adenocarcinoma Patients belong one follow risk group : Low : CS T1bT2a Gleason 26 PSA ≤ 10 , Intermediate : CS T2b Gleason 26 PSA ≤ 10 CS T1bT2b , Gleason 26 PSA ≤ 20 ng/ml Gleason 7 PSA ≤ 10 ng/ml Prostate volume : ≤ 100 cc ECOG performance status 01 Prior prostatectomy cryotherapy prostate Prior radiotherapy prostate lower pelvis Implanted hardware material would prohibit appropriate treatment plan treatment delivery , investigator 's opinion Chemotherapy malignancy last 5 year History invasive malignancy ( prostate cancer , basal squamous skin cancer ) last 5 year . Hormone ablation two month prior enrollment , treatment .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>CyberKnife</keyword>
	<keyword>Stereotactic Radiosurgery</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Radiation</keyword>
	<keyword>Prostate Tumor</keyword>
	<keyword>Prostate Surgery</keyword>
</DOC>